News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
634,019 Results
Type
Article (37421)
Company Profile (121)
Press Release (596466)
Multimedia
Podcasts (58)
Webinars (11)
Section
Business (172548)
Career Advice (2761)
Deals (32362)
Drug Delivery (91)
Drug Development (72581)
Employer Resources (159)
FDA (15676)
Job Trends (14579)
News (300131)
Policy (28992)
Tag
Academia (2668)
Academic (1)
Accelerated approval (14)
Adcomms (27)
Allergies (120)
Alliances (43318)
ALS (138)
Alzheimer's disease (1590)
Antibody-drug conjugate (ADC) (189)
Approvals (15782)
Artificial intelligence (388)
Autoimmune disease (65)
Automation (23)
Bankruptcy (289)
Best Places to Work (12092)
BIOSECURE Act (18)
Biosimilars (137)
Biotechnology (84)
Bladder cancer (121)
Brain cancer (43)
Breast cancer (470)
Cancer (3636)
Cardiovascular disease (286)
Career advice (2302)
Career pathing (35)
CAR-T (222)
CDC (38)
Cell therapy (609)
Cervical cancer (30)
Clinical research (61176)
Collaboration (1280)
Company closure (3)
Compensation (917)
Complete response letters (41)
COVID-19 (2547)
CRISPR (74)
C-suite (564)
Cystic fibrosis (129)
Data (4348)
Decentralized trials (1)
Denatured (12)
Depression (90)
Diabetes (404)
Diagnostics (6773)
Digital health (32)
Diversity (5)
Diversity, equity & inclusion (39)
Drug discovery (174)
Drug pricing (130)
Drug shortages (21)
Duchenne muscular dystrophy (179)
Earnings (70372)
Editorial (48)
Employer branding (21)
Employer resources (142)
Events (105297)
Executive appointments (968)
FDA (18044)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (1160)
Gene editing (158)
Generative AI (26)
Gene therapy (464)
GLP-1 (748)
Government (4191)
Grass and pollen (6)
Guidances (334)
Healthcare (19872)
HIV (42)
Huntington's disease (32)
IgA nephropathy (50)
Immunology and inflammation (183)
Immuno-oncology (11)
Indications (53)
Infectious disease (2758)
Inflammatory bowel disease (173)
Inflation Reduction Act (10)
Influenza (89)
Intellectual property (186)
Interviews (545)
IPO (16268)
IRA (39)
Job creations (2871)
Job search strategy (1895)
Kidney cancer (15)
Labor market (54)
Layoffs (482)
Leadership (32)
Legal (6389)
Liver cancer (75)
Longevity (11)
Lung cancer (505)
Lymphoma (248)
Machine learning (29)
Management (60)
Manufacturing (545)
MASH (129)
Medical device (14228)
Medtech (14251)
Mergers & acquisitions (17045)
Metabolic disorders (930)
Multiple sclerosis (125)
NASH (13)
Neurodegenerative disease (201)
Neuropsychiatric disorders (46)
Neuroscience (2528)
NextGen: Class of 2025 (6715)
Non-profit (4840)
Now hiring (44)
Obesity (396)
Opinion (257)
Ovarian cancer (131)
Pain (158)
Pancreatic cancer (162)
Parkinson's disease (236)
Partnered (25)
Patents (391)
Patient recruitment (305)
Peanut (55)
People (52543)
Pharmaceutical (34)
Pharmacy benefit managers (22)
Phase I (19062)
Phase II (27132)
Phase III (20224)
Pipeline (2614)
Policy (213)
Postmarket research (2018)
Preclinical (7837)
Press Release (62)
Prostate cancer (186)
Psychedelics (40)
Radiopharmaceuticals (266)
Rare diseases (593)
Real estate (4917)
Recruiting (66)
Regulatory (21610)
Reports (31)
Research institute (2465)
Resumes & cover letters (451)
Rett syndrome (15)
RNA editing (9)
RSV (61)
Schizophrenia (122)
Series A (183)
Series B (146)
Service/supplier (6)
Sickle cell disease (77)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (27)
Startups (3048)
State (2)
Stomach cancer (8)
Supply chain (86)
Tariffs (67)
The Weekly (45)
Vaccines (825)
Venture capital (52)
Weight loss (240)
Women's health (43)
Worklife (19)
Date
Today (77)
Last 7 days (596)
Last 30 days (2180)
Last 365 days (31392)
2025 (24648)
2024 (35957)
2023 (41286)
2022 (52113)
2021 (57039)
2020 (55564)
2019 (48731)
2018 (36629)
2017 (32100)
2016 (30368)
2015 (35472)
2014 (24629)
2013 (19205)
2012 (20726)
2011 (21532)
2010 (18624)
Location
Africa (766)
Alabama (77)
Alaska (7)
Arizona (190)
Arkansas (12)
Asia (36959)
Australia (6565)
California (9146)
Canada (2810)
China (837)
Colorado (387)
Connecticut (405)
Delaware (255)
Europe (85791)
Florida (1369)
Georgia (311)
Hawaii (2)
Idaho (60)
Illinois (722)
India (43)
Indiana (440)
Iowa (17)
Japan (311)
Kansas (115)
Kentucky (36)
Louisiana (16)
Maine (77)
Maryland (1196)
Massachusetts (6866)
Michigan (300)
Minnesota (538)
Mississippi (3)
Missouri (116)
Montana (32)
Nebraska (25)
Nevada (106)
New Hampshire (75)
New Jersey (2549)
New Mexico (30)
New York (2503)
North Carolina (1307)
North Dakota (10)
Northern California (4214)
Ohio (285)
Oklahoma (21)
Oregon (37)
Pennsylvania (1930)
Puerto Rico (18)
Rhode Island (43)
South America (1084)
South Carolina (48)
South Dakota (1)
Southern California (3563)
Tennessee (145)
Texas (1412)
United States (33580)
Utah (281)
Virginia (227)
Washington D.C. (73)
Washington State (776)
West Virginia (3)
Wisconsin (86)
Wyoming (1)
634,019 Results for "pharmalink ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
October 17, 2025
·
12 min read
Press Releases
AB Science will hold a virtual conference on Thursday, October 16, 2025 from 2pm to 3pm CET to provide an update on the Phase 1 study with AB8939
October 14, 2025
·
8 min read
Press Releases
AB Science announces the successful completion of a EUR 2.8 million private placement
October 17, 2025
·
11 min read
Press Releases
Nomination Committee of XVIVO Perfusion AB (publ)
September 8, 2025
·
2 min read
Press Releases
Announcement from the Annual General Meeting in Biovica International AB
September 23, 2025
·
8 min read
Press Releases
AB Science today reports its revenues for the first half of 2025 and provides an update on its activities
October 13, 2025
·
13 min read
Business
PharmaLink Inc. and Recall Results, Inc. Announce Strategic Partnership to Enhance Drug Safety and Recall Efficiency
PharmaLink Inc., a national leader in pharmaceutical reverse distribution, and Recall Results, a prominent provider of comprehensive recall management and support services, today announced a strategic partnership aimed at enhancing drug safety and recall efficiency in the pharmaceutical industry.
April 26, 2024
·
4 min read
Press Releases
AB Science announces a slight delay in the publication of its 2025 half-year financial report
October 1, 2025
·
2 min read
Press Releases
BioInvent International AB: Interim Report January - June 2025
August 26, 2025
·
3 min read
Press Releases
Notice Of Annual General Meeting in Biovica International AB
August 22, 2025
·
52 min read
1 of 63,402
Next
